Health Ministry introduces strict measures against fake or fabricated data
Until now, applicants found guilty of submitting fabricated data were liable to face only rejection of applications or cancellation of existing licences; the new provisions go a step further by imposing a temporary ban on future applications, aimed at deterring repeated violations
The Union Health Ministry has announced amendments to the Drugs Rules, 1945, aimed at combating the submission of fake or fabricated data in pharmaceutical applications. In a statement released on Thursday, August 6, 2026, the ministry explained that these new rules, which build upon existing provisions under the Drugs and Cosmetics Act, 1940, empower licensing authorities at both the national and state levels to bar entities from submitting new applications for a determined period.
Previously, offenders faced only application rejection or license cancellation. The revised rules introduce a temporary prohibition on future applications, designed to deter repeat violations. A crucial aspect of the amendments is the requirement for a show-cause notice before any debarment order is issued, ensuring fairness in the process.
The ministry also introduced an appeal mechanism for affected entities to contest the decision. According to the ministry, these changes are intended to promote accountability among pharmaceutical applicants, discourage regulatory misconduct, and ensure that drug approvals are grounded in reliable and scientifically validated evidence.
Written by urgent.news from The Hindu - Sci-Tech's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
